Skip to main content
Log in

Intermittent Parathyroid Hormone Injection Can Decrease Femoral Head Collapse in the Vascular Deprivation of Rat Femoral Head Model

  • Original Article
  • Published:
Indian Journal of Orthopaedics Aims and scope Submit manuscript

Abstract

Backgrounds

Intermittent parathyroid hormone (intermittent PTH) injection has been shown to improve osteogenesis. We hypothesized that intermittent PTH injection could stimulate osteogenesis during the early phase of vascular deprivation-induced femoral neck osteonecrosis in a rat model.

Materials and Methods

Eighteen Sprague-Dawley rats were divided into three groups (normal saline [CON], PTH 10 µg/kg [PTH-H], and PTH 1 µg/kg [PTH-L]) for 8 weeks by subcutaneous injection. All rats were sacrificed at postoperative 8 weeks, and all underwent a micro-computed tomography (µ-CT) examination for bone quality and quantity evaluation and histomorphometric analysis for microscopic histologic differences.

Results

Under µ-CT examination, both the PTH-H and PTH-L groups revealed less bone resorption than the control group. The PTH-H group had a better bone protective effect than the PTH-L group. Bone mineral density was increased in the PTH-H and PTH-L groups compared to the control group. The uninjured left femoral head was enlarged in both PTH groups. The histologic examination showed that both PTH groups had new bone and cartilage formation. The control group had only dead bone without any osteogenesis.

Conclusion

Intermittent PTH injection could decrease bone resorption and improve bone density, compared to the control group, in vascular deprivation of the femoral head in a rat model. High-level intermittent PTH injection had a better effect than low-level intermittent PTH injection.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Norman D, Reis D, Zinman C, Misselevich I, Boss JH. Vascular deprivation-induced necrosis of femoral head of the rat. An experiment model of avascular necrosis in the skeletal immature individual of Legg-Perthes disease. Int J Exp Pathol 1998;79:173–81.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Petrigliano FA, Lieberman JR. Osteonecrosis of the hip: Novel approaches to evaluation and treatment. Clin Orthop Relat Res 2007;465:53–62.

    PubMed  Google Scholar 

  3. Mont MA, Hungerford DS. Non-traumatic avascular necrosis of the femoral head. J Bone Joint Surg Am 1995;77:459–74.

    Article  CAS  PubMed  Google Scholar 

  4. Hartley WT, McAuley JP, Culpepper WJ, Engh CA Jr., Engh CA Sr. Osteonecrosis of the femoral head treated with cementless total hip arthroplasty. J Bone Joint Surg Am 2000;82-A: 1408–13.

    Article  Google Scholar 

  5. Hofstaetter JG, Wang J, Yan J, Glimcher MJ. Changes in bone microarchitecture and bone mineral density following experimental osteonecrosis of the hip in rabbits. Cells Tissues Organs 2006;184:138–47.

    Article  PubMed  Google Scholar 

  6. Glimcher MJ, Kenzora JE. The biology of osteonecrosis of the human femoral head and its clinical implications. III. Discussion of the etiology and genesis of the pathological sequelae; commments on treatment. Clin Orthop Relat Res 1979;140:273–312.

    Google Scholar 

  7. Poole KE, Reeve J. Parathyroid hormone – A bone anabolic and catabolic agent. Curr Opin Pharmacol 2005;5:612–7.

    Article  CAS  PubMed  Google Scholar 

  8. Hollnagel A, Ahrens M, Gross G. Parathyroid hormone enhances early and suppresses late stages of osteogenic and chondrogenic development in a BMP-dependent mesenchymal differentiation system (C3H10T1/2). J Bone Miner Res 1997;12:1993–2004.

    Article  CAS  PubMed  Google Scholar 

  9. Jilka RL, Weinstein RS, Bellido T, Roberson P, Parfitt AM, Manolagas SC. Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone. J Clin Invest 1999;104:439–46.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Neer RM, Arnaud CD, Zanchetta JR, Prince R, Gaich GA, Reginster JY, et al. Effect of parathyroid hormone (1–34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 2001;344:1434–41.

    Article  CAS  PubMed  Google Scholar 

  11. Peichl P, Holzer LA, Maier R, Holzer G. Parathyroid hormone 1–84 accelerates fracture-healing in pubic bones of elderly osteoporotic women. J Bone Joint Surg Am 2001;93:1583–7.

    Article  Google Scholar 

  12. Aspenberg P, Genant HK, Johansson T, Nino AJ, See K, Krohn K, et al. Teriparatide for acceleration of fracture repair in humans: A prospective, randomized, double-blind study of 102 postmenopausal women with distal radial fractures. J Bone Miner Res 2010;25:404–14.

    Article  CAS  PubMed  Google Scholar 

  13. Nishida S, Yamaguchi A, Tanizawa T, Endo N, Mashiba T, Uchiyama Y, et al. Increased bone formation by intermittent parathyroid hormone administration is due to the stimulation of proliferation and differentiation of osteoprogenitor cells in bone marrow. Bone 1994;15:717–23.

    Article  CAS  PubMed  Google Scholar 

  14. Davies J, Chambers TJ. Parathyroid hormone activates adhesion in bone marrow stromal precursor cells. J Endocrinol 2004;180:505–13.

    Article  CAS  PubMed  Google Scholar 

  15. Kang SY, Deshpande SS, Donneys A, Rodriguez JJ, Nelson NS, Felice PA, et al. Parathyroid hormone reverses radiation induced hypovascularity in a murine model of distraction osteogenesis. Bone 2013;56:9–15.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Zhou CH, Meng JH, Zhao CC, Ye CY, Zhu HX, Hu B, et al. PTH[1–34] improves the effects of core decompression in early-stage steroid-associated osteonecrosis model by enhancing bone repair and revascularization. PLoS One 2017;12:e0178781.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Neer RM, Arnaud CD, Zanchetta JR, Prince R, Gaich GA, Reginster JY, et al. Effect of parathyroid hormone (1–34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 2001;344:1434–44.

    Article  CAS  PubMed  Google Scholar 

  18. Chen YJ, Wang SP, Cheng FC, Hsu PY, Li YF, Wu J, et al. Intermittent parathyroid hormone improve bone microarchitecture of the mandible and femoral head in ovariectomized rats. BMC Musculoskelet Disord 2017;18:171.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Tao ZS, Zhou WS, Qiang Z, Tu KK, Huang ZL, Xu HM, et al. Intermittent administration of human parathyroid hormone (1–34) increases fixation of strontium-doped hydroxyapatite coating titanium implants via electrochemical deposition in ovariectomized rat femur. J Biomater Appl 2016;30:952–60.

    Article  CAS  PubMed  Google Scholar 

  20. Bi F, Shi Z, Jiang S, Guo P, Yan S. Intermittently administered parathyroid hormone [1–34] promotes tendon-bone healing in a rat model. Int J Mol Sci 2014;15:17366–79.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Schilcher J, Michaëlsson K, Aspenberg P. Bisphosphonate use and atypical fractures of the femoral shaft. N Engl J Med 2011;364:1728–37.

    Article  CAS  PubMed  Google Scholar 

  22. Chiang CY, Zebaze RM, Ghasem-Zadeh A, Iuliano-Burns S, Hardidge A, Seeman E, et al. Teriparatide improves bone quality and healing of atypical femoral fractures associated with bisphosphonate therapy. Bone 2013;52:360–5.

    Article  CAS  PubMed  Google Scholar 

  23. Reid IR, Cornish J. Epidemiology and pathogenesis of osteonecrosis of the jaw. Nat Rev Rheumatol 2011;8:90–6.

    Article  PubMed  Google Scholar 

  24. Kyrgidis A, Vahtsevanos K. Osteonecrosis of the jaw in patients receiving oral bisphosphonates. Osteoporos Int 2010;21:535–6.

    Article  PubMed  Google Scholar 

  25. Cheung A, Seeman E. Teriparatide therapy for alendronate associated osteonecrosis of the jaw. N Engl J Med 2010;363:2473–4.

    Article  CAS  PubMed  Google Scholar 

  26. Lau AN, Adachi JD. Resolution of osteonecrosis of the jaw after teriparatide [recombinant human PTH-(1–34)] therapy. J Rheumatol 2009;36:1835–7.

    Article  CAS  PubMed  Google Scholar 

  27. Kerachian MA, Harvey EJ, Cournoyer D, Chow TY, Nahal A, Séguin C. A rat model of early stage osteonecrosis induced by glucocorticoids. J Orthop Surg Res 2011;6:62.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Okazaki S, Nagoya S, Tateda K, Katada R, Mizuo K, Watanabe S, et al. Experimental rat model for alcohol-induced osteonecrosis of the femoral head. Int J Exp Pathol 2013;94:312–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Peled E, Bejar J, Zinman C, Boss JH, Reis DN, Norman D, et al. Prevention of distortion of vascular deprivation-induced osteonecrosis of the rat femoral head by treatment with alendronate. Arch Orthop Trauma Surg 2009;129:275–9.

    Article  PubMed  Google Scholar 

  30. Agarwala S, Shah S, Joshi VR. The use of alendronate in the treatment of avascular necrosis of the femoral head: Followup to eight years. J Bone Joint Surg Br 2009;91:1013–8.

    Article  CAS  PubMed  Google Scholar 

  31. Lai KA, Shen WJ, Yang CY, Shao CJ, Hsu JT, Lin RM. The use of alendronate to prevent early collapse of the femoral head in patients with nontraumatic osteonecrosis. A randomized clinical study. J Bone Joint Surg Am 2005;87:2155–9.

    Article  PubMed  Google Scholar 

  32. Chen CH, Chang JK, Lai KA, Hou SM, Chang CH, Wang GJ, et al. Alendronate in the prevention of collapse of the femoral head in nontraumatic osteonecrosis: A two-year multicenter, prospective, randomized, double-blind, placebo-controlled study. Arthritis Rheum 2012;64:1572–8.

    Article  CAS  PubMed  Google Scholar 

  33. Al Hadi H, Smerdon GR, Fox SW. Hyperbaric oxygen therapy suppresses osteoclast formation and bone resorption. J Orthop Res 2013;31:1839–44.

    CAS  PubMed  Google Scholar 

  34. Camporesi EM, Vezzani G, Bosco G, Mangar D, Bernasek TL. Hyperbaric oxygen therapy in femoral head necrosis. J Arthroplasty 2010;25:118–23.

    Article  PubMed  Google Scholar 

  35. Wang CJ, Wang FS, Yang KD, Weng LH, Hsu CC, Huang CS, et al. Shock wave therapy induces neovascularization at the tendon-bone junction. A study in rabbits. J Orthop Res 2003;21:984–9.

    Article  PubMed  Google Scholar 

  36. Wang CJ, Wang FS, Huang CC, Yang KD, Weng LH, Huang HY. Treatment of osteonecrosis of the femoral head-comparison of extracorporeal shockwave and core decompression and bone grafting. J Bone Joint Surg Am 2005;87:2380–7.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Chih-Wei Chiang.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chiang, CW., Chen, WC., Lee, CH. et al. Intermittent Parathyroid Hormone Injection Can Decrease Femoral Head Collapse in the Vascular Deprivation of Rat Femoral Head Model. JOIO 53, 340–346 (2019). https://doi.org/10.4103/ortho.IJOrtho_315_17

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.4103/ortho.IJOrtho_315_17

Keywords

Navigation